Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 853 to 855 of 855 entries
Sorted by: Best Match Show Resources per page
Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies.

The Journal of infection

Owen SI, Williams CT, Garrod G, Fraser AJ, Baldwin L, Brown L, Byrne RL, Collins AM, Cubas-Atienzar AI, de Vos M, Edwards T, Escadafal C, Ferreira DM, Fletcher T, Hyder-Wright A, Kay GA, Kontogianni K, Mason J, Menzies S, Mitsi E, Planche T, Sacks JA, Taylor J, Todd S, Tully C, Cuevas LE, Adams ER.
PMID: 34906597
J Infect. 2021 Dec 11; doi: 10.1016/j.jinf.2021.12.007. Epub 2021 Dec 11.

BACKGROUND: There are an abundance of commercially available lateral flow assays (LFAs) that detect antibodies to SARS-CoV-2. Whilst these are usually evaluated by the manufacturer, externally performed diagnostic accuracy studies to assess performance are essential. Herein we present an...

Cite
Owen SI, Williams CT, Garrod G, et al. Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies. J Infect. 2021;doi: 10.1016/j.jinf.2021.12.007.
Owen, S. I., Williams, C. T., Garrod, G., Fraser, A. J., Baldwin, L., Brown, L., Byrne, R. L., Collins, A. M., Cubas-Atienzar, A. I., de Vos, M., Edwards, T., Escadafal, C., Ferreira, D. M., Fletcher, T., Hyder-Wright, A., Kay, G. A., Kontogianni, K., Mason, J., Menzies, S., Mitsi, E., Planche, T., Sacks, J. A., Taylor, J., Todd, S., Tully, C., Cuevas, L. E., & Adams, E. R. (2021). Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies. The Journal of infection, . https://doi.org/10.1016/j.jinf.2021.12.007
Owen, Sophie I, et al. "Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies." The Journal of infection vol. (2021). doi: https://doi.org/10.1016/j.jinf.2021.12.007
Owen SI, Williams CT, Garrod G, Fraser AJ, Baldwin L, Brown L, Byrne RL, Collins AM, Cubas-Atienzar AI, de Vos M, Edwards T, Escadafal C, Ferreira DM, Fletcher T, Hyder-Wright A, Kay GA, Kontogianni K, Mason J, Menzies S, Mitsi E, Planche T, Sacks JA, Taylor J, Todd S, Tully C, Cuevas LE, Adams ER. Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies. J Infect. 2021 Dec 11; doi: 10.1016/j.jinf.2021.12.007. Epub 2021 Dec 11. PMID: 34906597; PMCID: PMC8664720.
Copy Download .nbib Format: NLM
Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit.

Frontiers in medicine

Suarez-Cuartin G, Gasa M, Bermudo G, Ruiz Y, Hernandez-Argudo M, Marin A, Trias-Sabria P, Cordoba A, Cuevas E, Sarasate M, Ariza A, Sabater J, Romero N, Subirana C, Molina-Molina M, Santos S.
PMID: 34277674
Front Med (Lausanne). 2021 Jul 01;8:711027. doi: 10.3389/fmed.2021.711027. eCollection 2021.

No abstract available.

Cite
Suarez-Cuartin G, Gasa M, Bermudo G, et al. Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit. Front Med (Lausanne). 2021;8:711027doi: 10.3389/fmed.2021.711027.
Suarez-Cuartin, G., Gasa, M., Bermudo, G., Ruiz, Y., Hernandez-Argudo, M., Marin, A., Trias-Sabria, P., Cordoba, A., Cuevas, E., Sarasate, M., Ariza, A., Sabater, J., Romero, N., Subirana, C., Molina-Molina, M., & Santos, S. (2021). Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit. Frontiers in medicine, 8711027. https://doi.org/10.3389/fmed.2021.711027
Suarez-Cuartin, Guillermo, et al. "Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit." Frontiers in medicine vol. 8 (2021): 711027. doi: https://doi.org/10.3389/fmed.2021.711027
Suarez-Cuartin G, Gasa M, Bermudo G, Ruiz Y, Hernandez-Argudo M, Marin A, Trias-Sabria P, Cordoba A, Cuevas E, Sarasate M, Ariza A, Sabater J, Romero N, Subirana C, Molina-Molina M, Santos S. Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit. Front Med (Lausanne). 2021 Jul 01;8:711027. doi: 10.3389/fmed.2021.711027. eCollection 2021. PMID: 34277674; PMCID: PMC8280318.
Copy Download .nbib Format: NLM
COVID-19 detection from CT scans using a two-stage framework.

Expert systems with applications

Basu A, Sheikh KH, Cuevas E, Sarkar R.
PMID: 35002099
Expert Syst Appl. 2022 Jan 01;116377. doi: 10.1016/j.eswa.2021.116377. Epub 2022 Jan 01.

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It may cause serious ailments in infected individuals and complications may lead to death. X-rays and Computed Tomography (CT) scans can be...

Cite
Basu A, Sheikh KH, Cuevas E, et al. COVID-19 detection from CT scans using a two-stage framework. Expert Syst Appl. 2022;116377doi: 10.1016/j.eswa.2021.116377.
Basu, A., Sheikh, K. H., Cuevas, E., & Sarkar, R. (2022). COVID-19 detection from CT scans using a two-stage framework. Expert systems with applications, 116377. https://doi.org/10.1016/j.eswa.2021.116377
Basu, Arpan, et al. "COVID-19 detection from CT scans using a two-stage framework." Expert systems with applications vol. (2022): 116377. doi: https://doi.org/10.1016/j.eswa.2021.116377
Basu A, Sheikh KH, Cuevas E, Sarkar R. COVID-19 detection from CT scans using a two-stage framework. Expert Syst Appl. 2022 Jan 01;116377. doi: 10.1016/j.eswa.2021.116377. Epub 2022 Jan 01. PMID: 35002099; PMCID: PMC8720180.
Copy Download .nbib Format: NLM
Showing 853 to 855 of 855 entries